FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 24, 2022

Results 1 through 17 of 17

IN VITRO AND IN VIVO DIAGNOSTIC SUBSTANCES - SIC # 2835

Ticker Exchange Company Financial Reports SIC #
ABMC Over the counter American Bio Medica Corporatio 2835
ACUT Over the counter AccuStem Sciences Inc 2835
APDN Nasdaq Applied DNA Sciences Inc 2835
AWH Nasdaq Aspira Womens Health Inc 2835
BIAF Nasdaq bioAffinity Technologies Inc 2835
CDMO Nasdaq Avid Bioservices Inc 2835
EXAS Nasdaq Exact Sciences Corp 2835
GH Nasdaq Guardant Health Inc 2835
LADX Over the counter LadRx Corp 2835
MODD Nasdaq Modular Medical Inc 2835
MYGN Nasdaq Myriad Genetics, Inc. 2835
NEOG Nasdaq Neogen Corp 2835
NTRA Nasdaq Natera Inc 2835
OSUR Nasdaq OraSure Technologies, Inc. 2835
TKNO Nasdaq Alpha Teknova Inc 2835
TRIB Nasdaq Trinity Biotech plc (ADR) 2835
WGS Nasdaq GeneDx Holdings Corp 2835
Results 0 through 17 of 17